Q4 results today: Swiggy, Dr Reddy's among 68 companies to announce earnings on Friday

Synopsis

The net play is gaining speed. Swiggy anticipates dependable gross growth, driven by speedy commerce and nutrient delivery. However, profitability whitethorn look pressure. Losses could widen. Dr Reddy's is projected to study a nett net increase. Revenue from operations is besides expected to grow. Several different companies, including ABB India and Bank of India, volition besides denote their results.

The 4th fourth earnings play is picking up momentum and connected Friday arsenic galore arsenic 68 companies volition denote their quarterly numbers. Key net to ticker retired see from Swiggy and Dr Reddy's.

Apart from the above, ABB India, Aditya Consumer Marketing, Bank of India, Birla Corp, Dhanlaxmi Bank, FGP, GRP, KPR Mill, Lloyds Enterprises, CE Info Systems among others volition besides state their results.

Swiggy Q4 expectations

Food transportation institution Swiggy is expected to study dependable gross maturation for the 4th fourth of FY25, driven by continued spot successful its speedy commerce (Instamart) and nutrient transportation businesses. However, profitability is apt to stay nether unit owed to precocious operating costs, peculiarly successful the Instamart segment, which continues to necessitate important investments.

The company’s consolidated gross is projected to emergence 26% year-on-year (YoY), supported by a crisp summation successful bid volumes for some nutrient transportation and Instamart. Meanwhile, losses are apt to widen up to Rs 1031 crore.

The company’s assertive absorption connected lawsuit acquisition, coupled with rising transportation and promotional costs, is expected to interaction profitability. Swiggy’s operational metrics successful the 4th whitethorn besides bespeak the interaction of seasonal demand, with an uptick successful nutrient transportation orders but astatine a precocious lawsuit acquisition cost.

According to Motilal Oswal, Swiggy is apt to study a gross of Rs 4,227 crore, driven by robust bid maturation successful its nutrient transportation business. However, the brokerage expects the company’s losses to widen arsenic a effect of higher discounts, accrued transportation costs, and elevated selling expenses.

Dr Reddy's Q4 Preview

Pharma large Dr Reddy’s Laboratories volition denote its Q4FY25 net connected Friday wherever the institution is expected to study a nett net maturation of 1.3% to 12% connected the year-on-year basis, according to estimates fixed by 4 brokerages. The bottommost enactment is apt to beryllium reported successful the scope of Rs 1,324 crore to Rs Rs 1,439 crore.

The gross from operations successful the January-March 4th of FY25 is expected to turn by 13%-18% with topline pegged successful the portion of Rs 7,981 crore to Rs 8,424 crore.

The estimates person been fixed by Nuvama Institutional Equities, Axis Securities, Yes Securities and Equirus Securities.

(Disclaimer: Recommendations, suggestions, views and opinions fixed by the experts are their own. These bash not correspond the views of Economic Times)

...moreless

...moreless